Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma

I. Škopljanac (Split, Croatia), I. Segrt (Split, Croatia), K. Mise (Split, Croatia), E. Lozo Vukovac (Split, Croatia), A. Tolic Biocina (Split, Croatia)

Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Session: Clinical management of pleural malignancies, including mesothelioma
Session type: Thematic Poster
Number: 2894
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Škopljanac (Split, Croatia), I. Segrt (Split, Croatia), K. Mise (Split, Croatia), E. Lozo Vukovac (Split, Croatia), A. Tolic Biocina (Split, Croatia). Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma. 2894

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: